Healthcare Finance Staff
Health insurer spending on treatment for painkiller dependence is on the rise, and proving to be one of several tools needed to curb the epidemic of opioid addiction.
Health insurers are betting on value-based payments, broadly defined, but providers still seem skittish.
Don't rule out chaos for next year's ICD-10 deadline, or maybe plan on it, if the latest readiness research is any indication.
Rethinking how it acquires information technologies seems to be giving one insurer an edge, letting it eke out a "trifecta" of lower costs, fewer unhappy customers, and increased revenue.
Network adequacy concerns are starting to generate renewed interest in new health plan provider mandates.
The parallels between the nation's ICD-10 switch and the popular fantasy epic are real.
Advances in molecular and genomic technology are creating a maze of new options for payers and patients replete with quite a few meaningful improvements as well as some dead ends.
The ranks of Medicaid are reaching record levels, giving payers and providers, especially, new opportunities.
The backlash against narrow networks continues, as more displeased individual health consumers take their grievances to the courts of law and public opinion.
In bundled payments, where once there was so much promise, there is now conflicting evidence.